Simplified image‐based dosimetry using planar images and patient‐specific S‐values

Abstract

AbstractBackgroundSingle time point measurement approach and hybrid dosimetry were proposed to simplify the dosimetry process. It is anticipated that utilizing patient‐specific S‐value would enable more accurate dosimetry assessment based on imaging compared to using the conventional MIRD S‐values.PurposeWe performed planar image‐based dosimetry scaled with a single SPECT image for the entire treatment cycle using patient‐specific S‐values (PSS dosimetry) of organs. PSS dosimetry could further simplify the dosimetry procedure compared with a conventional 2D planar/3D SPECT hybrid dosimetry, as PSS dosimetry requires only one SPECT/CT image for the treatment of the entire cycle, whereas the conventional hybrid dosimetry requires a SPECT/CT image for each treatment cycle.Methods177Lu‐DOTATATE SPECT/CT and planar image datasets acquired from Seoul National University Hospital (SNUH, Seoul, Republic of Korea) were utilized for the evaluation. Images were acquired 4, 24, 48, and 120 h after patients’ intravenous injection of 177Lu‐DOTATATE. Dose estimations based on a Monte Carlo (MC) simulation using the Geant4 Application for Emission Tomography (GATE) (v.8.2) were considered as the reference. Planar image‐based dosimetry scaled with a single SPECT image was performed using the patient‐specific S‐value (PSS). Briefly, the CT image was considered as the patient's anatomical reference and PSSs were quantified using the multiple voxel S‐value (VSV) method. Then, PSS dosimetry was performed by obtaining activity information from sequential planar images and a scaling factor derived from a single SPECT/planar image pair. Hybrid dosimetry using sequential planar images and a single SPECT image was performed for comparison. The absorbed doses of the kidneys, bone marrow (BM) in the lumbar spine, liver, and spleen calculated using the PSS and hybrid dosimetries were compared with the reference MC results.ResultsThe mean differences (MDs) of the self‐absorption S‐values between S‐value of OLINDA/EXM and PSS for the kidneys, liver, and spleen were −0.04%, −2.39%, and −2.62%, respectively. However, the differences in the self‐absorption S‐values were significantly higher for the BM (84.99%) and the remainder of the body (ROB) (280.84%). The absorbed doses estimated by the PSS and hybrid dosimetries showed relatively high errors compared with MC simulation result, regardless of the organ. In contrast, the PSS and hybrid dosimetries produced similar dose estimates. For the entire cycles of the treatment, the MDs of absorbed doses between PSS and hybrid dosimetries were −3.31%, −6.04%, 3.37%, and −2.17% for the kidneys, BM, liver, and spleen, respectively. Through a correlation analysis and the Wilcoxon signed‐rank test, we concluded that there was no significant difference between the results obtained by the two dosimetry methods.ConclusionsAs the PSS was derived using CT images with actual anatomical information and organ‐specific volume of interest (VOI), PSS dosimetry provided reliable results. PSS dosimetry was robust in estimating the absorbed dose for the later treatment cycles. Therefore, PSS dosimetry outperformed hybrid dosimetry in terms of dose estimation for a greater number of treatment cycles.